May 22, 2026 18:00 ET | Source: Calidi Biotherapeutics, Inc SAN DIEGO, May 22, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics,…
May 15, 2026 20:19 ET | Source: Regeneron Pharmaceuticals, Inc. The trial did not reach statistical significance for the primary…
GLG and Bloomberg Terminal® clients can now access the premium research provider's unblinded expert transcripts directly via Bloomberg's new conversational…
Sankaty Jet Capital, a wholly owned subsidiary of AIP Capital, has committed capital through a new secured mezzanine facilitySTAMFORD, Conn.…
ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome…
~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~…
April 30, 2026 01:30 ET | Source: NICOX SA Press Release Nicox Provides Full Year 2025 Financial Results and Corporate…
Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate Investigator Led…
AGOURA HILLS, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biopharmaceutical company…
– Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD – –…